Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Cyclobenzaprine · Cyclobenzaprine Hydrochloride, Flexeril

Small molecule · developed by Janssen Res And Dev

Approved FDA, Aug 1977
6 Registered trials

What is Cyclobenzaprine?

Cyclobenzaprine is a centrally acting skeletal muscle relaxant that acts primarily at the brain stem to reduce tonic somatic motor activity, influencing both gamma and alpha motor systems. It is studied in primary fibromyalgia, post-traumatic stress disorder, and healthy adults, including sublingual and intravenous formulations.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Cyclobenzaprine Hydrochloride, Flexeril, TNX-102, Amrix 30, Tonmya(R)
Drug type
Small molecule
Pathways
brain stem motor control (reduction of tonic somatic motor activity)
Therapy area
Musculoskeletal, Psychiatry
Developer
Janssen Res And Dev
In trials of
TNXP
FDA status
Approved as Cyclobenzaprine Hydrochloride, Flexeril (August 26, 1977), NDA017821 · FDA label
UNII
69O5WQQ5TI

✅ FDA-approved uses

From the indications section of the FDA label (version of Sep 1, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03841773 Phase 3 PTSD Terminated TNXP
NCT02589275 Phase 3 Primary Fibromyalgia Completed TNXP
NCT03443960 Phase 1 Healthy Subjects Completed TNXP
NCT01889173 Phase 1 Healthy Adults Completed TNXP
NCT01689259 Phase 1 Healthy Adults Completed TNXP
NCT01634412 Phase 1 Healthy Adults Completed TNXP

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Healthy AdultsHealthy SubjectsPrimary FibromyalgiaPTSD

Sources

Updated Nov 15, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.